newsfilter
← Latest News
GlobeNewswire·

Evaxion files amendment to registration statement related to 2025 EIB debt settlement agreement

COPENHAGEN, Denmark, November 9, 2026 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, has filed an